Surging demand for Ozempic and other GLP-1 drugs is adding up for some Minnesota employers. Why it matters: The popular ...
From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...
The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...
Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, ...
The study analyzed electronic health records from 708,406 patients diagnosed with breast cancer between January 2011 and ...
Use of GLP-1 receptor agonists, which have shown to be effective in diabetes and obesity treatment, is expanding into other ...
MedPage Today on MSN
GLP-1 drugs linked to lower epilepsy risk in diabetes patients
Ozempic may have neurologic benefit despite Alzheimer's setback, large study suggests ...
Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...
Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related ...
The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could ...
Love Is Blind alum Irina Solomonova has been using a GLP-1 to slim down. “I’m finishing my first month on GLP-1s. I’m on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback